Behçet's disease

Best Practice and Research: Clinical Rheumatology

Volumn 18, Issue 3, 2004, Pages 291-311

  Marshall, Sara E ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

51; Anti inflammatory therapy; Beh et's disease; HLA B; Immunosuppressive therapy; Systemic vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; COLCHICINE; CORTICOSTEROID; CYANOCOBALAMIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; ETANERCEPT; HLA B51 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; IRON DERIVATIVE; METHOTREXATE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYDRIATIC AGENT; PENICILLIN G; PENTOXIFYLLINE; PYRIDOXINE; SALAZOSULFAPYRIDINE; SUCRALFATE; TACROLIMUS; THALIDOMIDE; TUMOR NECROSIS FACTOR ANTIBODY; UNINDEXED DRUG; WARFARIN;

AGRANULOCYTOSIS; ANEMIA; ARTHROPATHY; BEHCET DISEASE; BLOOD DYSCRASIA; CANCER; CAUCASIAN; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COARSE FACE; DIABETES MELLITUS; DISEASE CLASSIFICATION; DNA POLYMORPHISM; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; EYE INFLAMMATION; FLU LIKE SYNDROME; GASTROINTESTINAL DISEASE; GENETIC SUSCEPTIBILITY; GENITAL ULCER; GINGIVA HYPERTROPHY; HEMOLYSIS; HLA SYSTEM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; INFECTION; INFERTILITY; KIDNEY DISEASE; LABORATORY TEST; METHEMOGLOBINEMIA; MOUTH ULCER; NEUROLOGIC DISEASE; NEUROTOXICITY; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; SOUTHERN EUROPE; TERATOGENICITY; THROMBOSIS;

ADULT; BEHCET SYNDROME; CHILD; FEMALE; HUMANS; MALE; PREGNANCY;

EID: 3242666233     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2004.02.008     Document Type: Review

References (175)

1. Behcet H. Uber rezidivierende, aphthose, dürch ein Virus verursachte Geshwure am Munde, am Auge und an den Genitalien Dematologische Wochenschrift 36 1937 1152-1157
2. Idil A. Gurler A. Boyvat A. et al The prevalence of Behcet's disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey Ophthalmic Epidemiology 9 2002 325-331
3. Azizlerli G. Akdag Kose A. Sarica R. et al Prevalence of Behcet's disease in Istanbul, Turkey International Journal of Dermatology 42 2003 803-806
4. Sakane T. Takeno M. Suzuki N. Inaba G. Behcet's disease New England Journal of Medicine 341 1999 1284-1291
5. Jacyk W.K. Behcet's disease in South African blacks: report of five cases Journal of the American Academy of Dermatology 30 5 part 2 1994 869-873
6. Taylor C.B. Low N. Raj S. et al Behcet's syndrome progressing to gastrointestinal perforation in a West African male British Journal of Rheumatology 36 1997 498-501
7. Poon W. Verity D.H. Larkin G.L. Graham E.M. Stanford M.R. Behcet's disease in patients of west African and Afro-Caribbean origin British Journal of Ophthalmology 87 2003 876-878
8. Kone-Paut I. Gorchakoff-Molinas A. Weschler B. Touitou I. Paediatric Behcet's disease in France Annals of the Rheumatic Diseases 61 2002 655-656
9. Tursen U. Gurler A. Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease International Journal of Dermatology 42 2003 346-351
10. Bang D. Yoon K.H. Chung H.G. Choi E.H. Lee E.S. Lee S. Epidemiological and clinical features of Behcet's disease in Korea Yonsei Medical Journal 38 1997 428-436
11. Kone-Paut I. Geisler I. Wechsler B. et al Familial aggregation in Behcet's disease: high frequency in siblings and parents of pediatric probands Journal of Pediatrics 135 1999 89-93
12. Gul A. Inanc M. Ocal L. Aral O. Konice M. Familial aggregation of Behcet's disease in Turkey Annals of the Rheumatic Diseases 59 2000 622-625
13. Ohno S. Ohguchi M. Hirose S. Matsuda H. Wakisaka A. Aizawa M. Close association of HLA-Bw51 with Behcet's disease Archives of Ophthalmology 100 1982 1455-1458
14. Verity D.H. Marr J.E. Ohno S. Wallace G.R. Stanford M.R. Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives Tissue Antigens 54 1999 213-220
15. Kotter I. Gunaydin I. Stubiger N. et al Comparative analysis of the association of HLA-B*51 suballeles with Behcet's disease in patients of German and Turkish origin Tissue Antigens 58 2001 166-170
16. Ahmad T. Wallace G.R. James T. et al Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis and Rheumatism 48 2003 807-813
17. Ota M. Mizuki N. Katsuyama Y. et al The critical region for Behcet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping American Journal of Human Genetics 64 1999 1406-1410
18. Ahmad T. Neville M. Marshall S.E. et al Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC Human Molecular Genetics 12 2003 647-656
19. Gul A. Hajeer A.H. Worthington J. Ollier W.E. Silman A.J. Linkage mapping of a novel susceptibility locus for Behcet's disease to chromosome 6p22-23 Arthritis and Rheumatism 44 2001 2693-2696
20. Toydemir P.B. Elhan A.H. Tukun A. et al Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behcet's disease Journal of Rheumatology 27 2000 2849-2854
21. Gul A. Ozbek U. Ozturk C. Inanc M. Konice M. Ozcelik T. Coagulation factor V gene mutation increases the risk of venous thrombosis in behcet's disease British Journal of Rheumatology 35 1996 1178-1180
22. Gurgey A. Balta G. Boyvat A. Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease Blood Coagulation and Fibrinolysis 14 2003 121-124
23. Salvarani C. Boiardi L. Casali B. et al Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease Journal of Rheumatology 29 2002 535-540
24. Boiardi L. Salvarani C. Casali B. et al Intercellular adhesion molecule-1 gene polymorphisms in Behcet's Disease Journal of Rheumatology 28 2001 1283-1287
25. Verity D.H. Vaughan R.W. Kondeatis E. et al Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease European Journal of Immunogenetics 27 2000 73-76
26. Zouboulis C.C. Kotter I. Djawari D. et al Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe Yonsei Medical Journal 38 1997 411-422
27. Hirohata T. Kuratsune M. Nomura A. Jimi S. Prevalence of Behcet's syndrome in Hawaii. With particular reference to the comparison of the Japanese in Hawaii and Japan Hawaii Medical Journal 34 1975 244-246
28. Eglin R.P. Lehner T. Subak-Sharpe J.H. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers Lancet ii 1982 1356-1361
29. Studd M. McCance D.J. Lehner T. Detection of HSV-1 DNA in patients with Behcet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction Journal of Medical Microbiology 34 1991 39-43
30. Nomura Y. Kitteringham N. Shiba K. Goseki M. Kimura A. Mineshita S. Use of the highly sensitive PCR method to detect the herpes simplex virus type 1 genome and its expression in samples from Behcet disease patients Journal of Medical and Dental Science 45 1998 51-58
31. Aksu K. Kabasakal Y. Sayiner A. et al Prevalences of hepatitis A, B, C and E viruses in Behcet's disease Rheumatology (Oxford) 38 1999 1279-1281
32. Ilter N. Senol E. Gurer M.A. Oztas M.O. Behcet's disease and HCV infection International Journal of Dermatology 39 2000 396-397
33. Kiraz S. Ozturk M.A. Ertenli I. Calguneri M. Parvovirus B19 infection in Behcet's disease Annals of the Rheumatic Diseases 60 2001 814-815
34. Lehner T. Lavery E. Smith R. van der Zee R. Mizushima Y. Shinnick T. Association between the 65-kilodalton heat shock protein. Streptococcus sanguis, and the corresponding antibodies in Behcet's syndrome Infection and Immunity 59 1991 1434-1441
35. Isogai E. Isogai H. Kotake S. et al Detection of antibodies against Borrelia burgdorferi in patients with uveitis American Journal of Ophthalmology 112 1991 23-30
36. Avci O. Ellidokuz E. Simsek I. Buyukgebiz B. Gunes A.T. Helicobacter pylori and Behcet's disease Dermatology 199 1999 140-143
37. Behcet's Disease Research Committee of Japan Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet's disease-a multicenter study. The Behcet's Disease Research Committee of Japan Journal of Rheumatology 16 1989 506-511
38. Mizushima Y. Matsuda T. Hoshi K. Ohno S. Induction of Behcet's disease symptoms after dental treatment and streptococcal antigen skin test Journal of Rheumatology 15 1988 1029-1030
39. Kaneko F. Oyama N. Nishibu A. Streptococcal infection in the pathogenesis of Behcet's disease and clinical effects of minocycline on the disease symptoms Yonsei Medical Journal 38 1997 444-454
40. Tanaka T. Yamakawa N. Koike N. Suzuki J. Mizuno F. Usui M. Behcet's disease and antibody titers to various heat-shock protein 60s Ocular Immunology and Inflammation 7 1999 69-74
41. Krause I. Monselise Y. Milo G. Weinberger A. Anti-Saccharomyces cerevisiae antibodies-a novel serologic marker for Behcet's disease Clinical and Experimental Rheumatology 20 4 supplement 26 2002 S21-S24
42. Kim B.G. Kim Y.S. Kim J.S. Jung H.C. Song I.S. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease Diseases of the Colon and Rectum 45 2002 1062-1069
43. Sakane T. Suzuki N. Nagafuchi H. Etiopathology of Behcet's disease: immunological aspects Yonsei Medical Journal 38 1997 350-358
44. Benoist C. Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nature Immunology 2 2001 797-801
45. Yazici H. The place of Behcet's syndrome among the autoimmune diseases International Review of Immunology 14 1997 1-10
46. Direskeneli H. Keser G. D'Cruz D. et al Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behcet's disease Clinical Rheumatology 14 1995 55-61
47. Lee K.H. Chung H.S. Bang D. Lee S. Behcet's disease sera containing antiendothelial cell antibodies promote adhesion of T lymphocytes to cultured human dermal microvascular endothelial cells Yonsei Medical Journal 40 1999 152-158
48. de Smet M.D. Ramadan A. Circulating antibodies to inducible heat shock protein 70 in patients with uveitis Ocular Immunology and Inflammation 9 2001 85-92
49. Matsui T. Otsuka M. Maenaka K. et al Detection of autoantibodies to killer immunoglobulin-like receptors using recombinant fusion proteins for two killer immunoglobulin-like receptors in patients with systemic autoimmune diseases Arthritis and Rheumatism 44 2001 384-388
50. Mor F. Weinberger A. Cohen I.R. Identification of alpha-tropomyosin as a target self-antigen in Behcet's syndrome European Journal of Immunology 32 2002 356-365
51. Matsui T. Kurokawa M. Kobata T. et al Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases Journal of Immunology 162 1999 4328-4335
52. Orem A. Cimsit G. Deger O. Vanizor B. Karahan S.C. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behcet's disease Dermatology 198 1999 243-246
53. Yamamoto J.H. Minami M. Inaba G. Masuda K. Mochizuki M. Cellular autoimmunity to retinal specific antigens in patients with Behcet's disease British Journal of Ophthalmology 77 1993 584-589
54. de Smet M.D. Dayan M. Prospective determination of T-cell responses to S-antigen in Behcet's disease patients and controls Investigations in Ophthalmology and Visual Science 41 2000 3480-3484
55. Freysdottir J. Lau S. Fortune F. Gammadelta T cells in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS) Clinical and Experimental Immunology 118 1999 451-457
56. Hamzaoui K. Hamzaoui A. Guemira F. Bessioud M. Hamza M. Ayed K. Cytokine profile in Behcet's disease patients. Relationship with disease activity Scandinvian Journal of Rheumatology 31 2002 205-210
57. Frassanito M.A. Dammacco R. Cafforio P. Dammacco F. Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12 Arthritis and Rheumatism 42 1999 1967-1974
58. Hirohata S. Kikuchi H. Behcet's disease Arthritis Research 5 2003 139-146
59. Jorizzo J.L. Abernethy J.L. White W.L. et al Mucocutaneous criteria for the diagnosis of Behcet's disease: an analysis of clinicopathologic data from multiple international centers Journal of the American Academy of Dermatology 32 1995 968-976
60. Ergun T. Gurbuz O. Harvell J. Jorizzo J. White W. The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behcet's disease International Journal of Dermatology 37 1998 929-933
61. Akoglu T.F. Direskeneli H. Yazici H. Lawrence R. TNF, soluble IL-2R and soluble CD-8 in Behcet's disease Journal of Rheumatology 17 1990 1107-1108
62. Muftuoglu A.U. Yazici H. Yurdakul S. et al Behcet's disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity International Journal of Dermatology 25 1986 235-239
63. Aygunduz M. Bavbek N. Ozturk M. Kaftan O. Kosar A. Kirazli S. Serum beta 2-microglobulin reflects disease activity in Behcet's disease Rheumatology International 22 2002 5-8
64. Accardo-Palumbo A. Triolo G. Carbone M.C. Ferrante A. Ciccia F. Giardina E. Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behcet's disease Clinical and Experimental Rheumatology 18 2000 495-498
65. Takeno M. Kariyone A. Yamashita N. et al Excessive function of peripheral blood neutrophils from patients with Behcet's disease and from HLA-B51 transgenic mice Arthritis and Rheumatism 38 1995 426-433
66. Shapiro S. Olson D.L. Chellemi S.J. The association between smoking and aphthous ulcers Oral Surgery, Oral Medicine, Oral Pathology 30 1970 624-630
67. Axell T. Henricsson V. Association between recurrent aphthous ulcers and tobacco habits Scandinavian Journal of Dental Research 93 1985 239-242
68. Soy M. Erken E. Konca K. Ozbek S. Smoking and Behcet's disease Clinical Rheumatology 19 2000 508-509A
69. Scheid P. Bohadana A. Martinet Y. Nicotine patches for aphthous ulcers due to Behcet's syndrome New England Journal of Medicine 343 2000 1816-1817
70. Kural-Seyahi E. Fresko I. Seyahi N. et al The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center Medicine (Baltimore) 82 2003 60-76
71. Muhaya M. Lightman S. Ikeda E. et al Behcet's disease in Japan and in Great Britain: a comparative study Ocular Immunology and Inflammation 8 2000 141-148
72. Verity D.H. Wallace G.R. Vaughan R.W. Stanford M.R. Behcet's disease: from Hippocrates to the third millennium British Journal of Ophthalmology 87 2003 1175-1183
73. Diri E. Mat C. Hamuryudan V. Yurdakul S. Hizli N. Yazici H. Papulopustular skin lesions are seen more frequently in patients with Behcet's syndrome who have arthritis: a controlled and masked study Annals of the Rheumatic Diseases 60 2001 1074-1076
74. Gul A. Esin S. Dilsen N. Konice M. Wigzell H. Biberfeld P. Immunohistology of skin pathergy reaction in Behcet's disease British Journal of Dermatology 132 1995 901-907
75. Fresko I. Yazici H. Bayramicli M. Yurdakul S. Mat C. Effect of surgical cleaning of the skin on the pathergy phenomenon in Behcet's syndrome Annals of the Rheumatic Diseases 52 1993 619-620
76. Yazici H. Tuzun Y. Pazarli H. et al Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome Annals of the Rheumatic Diseases 43 1984 783-789
77. Bang D. Lee J.H. Lee E.S. et al Epidemiologic and clinical survey of Behcet's disease in Korea: the first multicenter study Journal of Korean Medical Science 16 2001 615-618
78. Davies P.G. Fordham J.N. Kirwan J.R. Barnes C.G. Dinning W.J. The pathergy test and Behcet's syndrome in Britain Annals of the Rheumatic Diseases 43 1984 70-73
79. Benamour S. Zeroual B. Alaoui F.Z. Joint manifestations in Behcet's disease. A review of 340 cases Revue Rhumatologie (English Edition) 65 1998 299-307
80. Kuzu M.A. Ozaslan C. Koksoy C. Gurler A. Tuzuner A. Vascular involvement in Behcet's disease: 8-year audit World Journal of Surgery 18 1994 948 953 discussion 953-954
81. Hamuryudan V. Yurdakul S. Moral F. et al Pulmonary arterial aneurysms in Behcet's syndrome: a report of 24 cases British Journal of Rheumatology 33 1994 48-51
82. Mader R. Ziv M. Adawi M. Lavi I. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behcet's disease Journal of Rheumatology 26 1999 2404-2408
83. Espinosa G. Font J. Tassies D. et al Vascular involvement in Behcet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin American Journal of Medicine 112 2002 37-43
84. Yurdakul S. Tuzuner N. Yurdakul I. Hamuryudan V. Yazici H. Gastrointestinal involvement in Behcet's syndrome: a controlled study Annals of the Rheumatic Diseases 55 1996 208-210
85. Bayraktar Y. Ozaslan E. Van Thiel D.H. Gastrointestinal manifestations of Behcet's disease Journal of Clinical Gastroenterology 30 2000 144-154
86. Kyle S.M. Yeong M.L. Isbister W.H. Clark S.P. Bechet's colitis: a differential diagnosis in inflammations of the large intestine Australian and New Zealand Journal of Surgery 61 1991 547-550
87. Akman-Demir G. Serdaroglu P. Tasci B. Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group Brain 122 part 11 1999 2171-2182
88. Siva A. Kantarci O.H. Saip S. et al Behcet's disease: diagnostic and prognostic aspects of neurological involvement Journal of Neurology 248 2001 95-103
89. Uzun S. Alpsoy E. Durdu M. Akman A. The clinical course of Behcet's disease in pregnancy: a retrospective analysis and review of the literature Journal of Dermatology 30 2003 499-502
90. Marsal S. Falga C. Simeon C.P. Vilardell M. Bosch J.A. Behcet's disease and pregnancy relationship study British Journal of Rheumatology 36 1997 234-238
91. Kone-Paut I. Yurdakul S. Bahabri S.A. et al Clinical features of Behcet's disease in children: an international collaborative study of 86 cases Journal of Pediatrics 132 1998 721-725
92. Kari J.A. Shah V. Dillon M.J. Behcet's disease in UK children: clinical features and treatment including thalidomide Rheumatology (Oxford) 40 2001 933-938
93. Mason R.M. Barnes C.G. Behcet's syndrome with arthritis Annals of the Rheumatic Diseases 28 1969 95-103
94. Mizushima Y. Recent research into Behcet's disease in Japan International Journal of Tissue Reactions 10 1988 59-65
95. O'Duffy J.D. Critères proposés pour le diagnostic de la maladie de Behcet et notes thérapeutiques Revue Med 36 1974 2371-2379
96. Dilsen N. Donice M. Aral O. Our diagnostic criteria of Behcet's disease-an overview In Lehner T. (Ed.) Recent Advances in Behcet's Disease. International Congress Series 1986 177-180
97. International Study Group for Behcet's Disease Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease Lancet 335 1990 1078-1080
98. Tunc R. Uluhan A. Melikoglu M. Ozyazgan Y. Ozdogan H. Yazici H. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behcet's syndrome Clinical and Experimental Rheumatology 19 5 supplement 24 2001 S45-S47
99. O'Neill T.W. Rigby A.S. Silman A.J. Barnes C. Validation of the International Study Group criteria for Behcet's disease British Journal of Rheumatology 33 1994 115-117
100. Bhakta B.B. Brennan P. James T.E. Chamberlain M.A. Noble B.A. Silman A.J. Behcet's disease: evaluation of a new instrument to measure clinical activity Rheumatology (Oxford) 38 1999 728-733
101. Lawton G. Bhakta B.B. Chamberlain M.A. Tennant A. The Behcet's disease activity index Rheumatology (Oxford) 2003
102. Kontogiannis V. Powell R.J. Behcet's disease Postgraduate Medical Journal 76 2000 629-637
103. Alpsoy E.E.H. Durusoy C. Yilmaz E. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behcet disease: a randomized, placebo-controlled, double-blind study Archives of Dermatology 135 1999 529-532
104. Kaklamani V.G. Kaklamanis P.G. Treatment of Behcet's disease-an update Seminars in Arthritis and Rheumatism 30 2001 299-312
105. Barnes C.G. Yazici H. Behcet's syndrome Rheumatology (Oxford) 38 1999 1171-1174
106. Whitcup S.M. Salvo Jr. E.C. Nussenblatt R.B. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet's disease American Journal of Ophthalmology 118 1994 39-45
107. Yazici H. Yurdakul S. Hamuryudan V. Behcet disease Current Opinion in Rheumatology 13 2001 18-22
108. Binder A.I. Graham E.M. Sanders M.D. Dinning W. James D.G. Denman A.M. Cyclosporin A in the treatment of severe Behcet's uveitis British Journal of Rheumatology 26 1987 285-291
109. Masuda K. Nakajima A. Urayama A. Nakae K. Kogure M. Inaba G. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease Lancet i 1989 1093-1096
110. Ozyazgan Y. Yurdakul S. Yazici H. et al Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial British Journal of Ophthalmology 76 1992 241-243
111. Kotake S. Higashi K. Yoshikawa K. Sasamoto Y. Okamoto T. Matsuda H. Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy Ophthalmology 106 1999 586-589
112. Kilmartin D.J. Forrester J.V. Dick A.D. Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis Ocular Immunology and Inflammation 6 1998 101-109
113. Tanabe K. Calcineurin inhibitors in renal transplantation: what is the best option? Drugs 63 2003 1535-1548
114. Yazici H. Pazarli H. Barnes C.G. et al A controlled trial of azathioprine in Behcet's syndrome New England Journal of Medicine 322 1990 281-285
115. Hamuryudan V. Ozyazgan Y. Hizli N. et al Azathioprine in Behcet's syndrome: effects on long-term prognosis Arthritis and Rheumatism 40 1997 769-774
116. Greenwood A.J. Stanford M.R. Graham E.M. The role of azathioprine in the management of retinal vasculitis Eye 12 part 5 1998 783-788
117. Sfikakis P.P. Theodossiadis P.G. Katsiari C.G. Kaklamanis P. Markomichelakis N.N. Effect of infliximab on sight-threatening panuveitis in Behcet's disease Lancet 358 2001 295-296
118. Estrach C. Mpofu S. Moots R.J. Behcet's syndrome: response to infliximab after failure of etanercept Rheumatology (Oxford) 41 2002 1213-1214
119. van Deventer S.J. Transmembrane TNF-alpha, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's disease Gastroenterology 121 2001 1242-1246
120. Sfikakis P.P. Behcet's disease: a new target for anti-tumour necrosis factor treatment Annals of the Rheumatic Diseases 61 supplement 2 2002 ii51-ii53
121. Zouboulis C.C. Orfanos C.E. Treatment of Adamantiades-Behcet disease with systemic interferon alfa Archives of Dermatology 134 1998 1010-1016
122. Zouboulis C.C. Treudler R. Orfanos C.E. Adamantiades-Behcet disease. Therapeutic administration of systemic recombinant interferon-alpha-2a Hautarzt 44 1993 440-445
123. Hamuryudan V. Moral F. Yurdakul S. et al Systemic interferon alpha 2b treatment in Behcet's syndrome Journal of Rheumatology 21 1994 1098-1100
124. Azizlerli G. Sarica R. Kose A. et al Interferon alfa-2a in the treatment of Behcet's disease Dermatology 192 1996 239-241
125. O'Duffy J.D. Calamia K. Cohen S. et al Interferon-alpha treatment of Behcet's disease Journal of Rheumatology 25 1998 1938-1944
126. Georgiou S. Monastirli A. Pasmatzi E. Gartaganis S. Goerz G. Tsambaos D. Efficacy and safety of systemic recombinant interferon-alpha in Behcet's disease Journal of Internal Medicine 243 1998 367-372
127. Demiroglu H. Ozcebe O.I. Barista I. Dundar S. Eldem B. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behcet's disease: a randomised trial Lancet 355 2000 605-609
128. Horton R. Retraction: interferon alfa-2b...in Behcet's disease Lancet 356 2000 1292
129. Sayek I. Behcet's disease and interferon: flaws in research integrity of randomised trial Lancet 356 2000 1351
130. Alpsoy E. Durusoy C. Yilmaz E. et al Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study Archives of Dermatology 138 2002 467-471
131. Gordon J.N. Goggin P.M. Thalidomide and its derivatives: emerging from the wilderness Postgraduate Medical Journal 79 2003 127-132
132. Revuz J. Guillaume J.C. Janier M. et al Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis Archives of Dermatology 126 1990 923-927
133. Hamuryudan V. Mat C. Saip S. et al Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial Annals of Internal Medicine 128 1998 443-450
134. Powell R.J. New roles for thalidomide British Medical Journal 313 1996 377-378
135. Ehrlich G.E. Behcet disease and the emergence of thalidomide Annals of Internal Medicine 128 1998 494-495
136. Powell R.J. Gardner-Medwin J.M. Guideline for the clinical use and dispensing of thalidomide Postgraduate Medical Journal 70 1994 901-904
137. Zeldis J.B. Williams B.A. Thomas S.D. Elsayed M.E. S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide Clinical Therapeutics 21 1999 319-330
138. Gardner-Medwin J.M. Smith N.J. Powell R.J. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behcet's disease: use of neurophysiological studies to detect thalidomide neuropathy Annals of the Rheumatic Diseases 53 1994 828-832
139. Windmeier C. Gressner A.M. Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis General Pharmacology 29 1997 181-196
140. Gan X.H. Robin J.P. Huerta J.M. Braquet P. Bonavida B. Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative Journal of Clinical Immunology 14 1994 280-288
141. Lazarczyk M. Grzela T. Korczak-Kowalska G. et al Pentoxifylline inhibits perforin-dependent natural cytotoxicity in vitro Oncology Reports 9 2002 423-426
142. Hill H. Augustine N. Newton J. Shigeoka A. Morris E. Sacchi F. Correction of a developmental defect in neutrophil activation and movement American Journal of Pathology 128 1987 307-314
143. Yasui K. Ohta K. Kobayashi M. Aizawa T. Komiyama A. Successful treatment of Behcet disease with pentoxifylline Annals of Internal Medicine 124 1996 891-893
144. Yasui K. Komiyama A. Takabayashi Y. Fujikawa S. Behcet's disease in children Journal of Pediatrics 134 1999 249-251
145. Wolf R. Tuzun B. Tuzun Y. Dapsone: unapproved uses or indications Clinics in Dermatology 18 2000 37-53
146. Sharquie K.E. Najim R.A. Abu-Raghif A.R. Dapsone in Behcet's disease: a double-blind, placebo-controlled, cross-over study Journal of Dermatology 29 2002 267-279
147. Matsumura N. Mizushima Y. Leucocyte movement and colchicine treatment in Behcet's disease Lancet ii 1975 813
148. Aktulga E. Altac M. Muftuoglu A. et al A double blind study of colchicine in Behcet's disease Haematologica 65 1980 399-402
149. Yurdakul S. Mat C. Tuzun Y. et al A double-blind trial of colchicine in Behcet's syndrome Arthritis and Rheumatism 44 2001 2686-2692
150. Porter S.R. Hegarty A. Kaliakatsou F. Hodgson T.A. Scully C. Recurrent aphthous stomatitis Clinics in Dermatology 18 2000 569-578
151. Calguneri M. Kiraz S. Ertenli I. Benekli M. Karaarslan Y. Celik I. The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet's disease. A randomized clinical trial Arthritis and Rheumatism 39 1996 2062-2065
152. Calguneri M. Ertenli I. Kiraz S. Erman M. Celik I. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet's disease Dermatology 192 1996 125-128
153. Hirohata S. Suda H. Hashimoto T. Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease Journal of Neurological Science 159 1998 181-185
154. Jorizzo J.L. White W.L. Wise C.M. Zanolli M.D. Sherertz E.F. Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behcet's disease Journal of the American Academy of Dermatology 24 6 part 1 1991 973-978
155. Tolia V. Abdullah A. Thirumoorthi M.C. Chang C.H. A case of Behcet's disease with intestinal involvement due to Crohn's disease American Journal of Gastroenterology 84 1989 322-325
156. Naganuma M. Iwao Y. Inoue N. et al Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behcet's disease American Journal of Gastroenterology 95 2000 2848-2851
157. Adler Y.D. Mansmann U. Zouboulis C.C. Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behcet's disease Dermatology 203 2001 322-324
158. Chan T.M. Li F.K. Tang C.S. et al Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group New England Journal of Medicine 343 2000 1156-1162
159. Moral F. Hamuryudan V. Yurdakul S. Yazici H. Inefficacy of azapropazone in the acute arthritis of Behcet's syndrome: a randomized, double blind, placebo controlled study Clinical and Experimental Rheumatology 13 1995 493-495
160. Davies U.M. Palmer R.G. Denman A.M. Treatment with acyclovir does not affect orogenital ulcers in Behcet's syndrome: a randomized double-blind trial British Journal of Rheumatology 27 1988 300-302
161. Lockwood C.M. Hale G. Waldman H. Jayne D.R. Remission induction in Behcet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H Rheumatology (Oxford) 2003
162. Mamo J.G. Treatment of Behcet disease with chlorambucil. A follow-up report Archives of Ophthalmology 94 1976 580-583
163. Hassard P.V. Binder S.W. Nelson V. Vasiliauskas E.A. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: a case report Gastroenterology 120 2001 995-999
164. Travis S.P. Czajkowski M. McGovern D.P. Watson R.G. Bell A.L. Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody Gut 49 2001 725-728
165. Munoz-Fernandez S. Hidalgo V. Fernandez-Melon J. Schlincker A. Martin-Mola E. Effect of infliximab on threatening panuveitis in Behcet's disease Lancet 358 2001-1644
166. Robertson L.P. Hickling P. Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with infliximab Rheumatology (Oxford) 40 2001 473-474
167. Goossens P.H. Verburg R.J. Breedveld F.C. Remission of Behcet's syndrome with tumour necrosis factor alpha blocking therapy Annals of the Rheumatic Diseases 60 2001 637
168. Rozenbaum M. Rosner I. Portnoy E. Remission of Behcet's syndrome with TNFalpha blocking treatment Annals of the Rheumatic Diseases 61 2002 283-284
169. Triolo G. Vadala M. Accardo-Palumbo A. et al Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behcet's disease Annals of the Rheumatic Diseases 61 2002 560-561
170. Licata G. Pinto A. Tuttolomondo A. et al Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behcet's syndrome Annals of the Rheumatic Diseases 62 2003 280-281
171. Gulli S. Arrigo C. Bocchino L. et al Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report BMC Musculoskeletal Disorders 4 2003 19
172. Kram M.T. May L.D. Goodman S. Molinas S. Behcet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case Diseases of the Colon and Rectum 46 2003 118-121
173. Joseph A. Raj D. Dua H.S. Powell P.T. Lanyon P.C. Powell R.J. Infliximab in the treatment of refractory posterior uveitis Ophthalmology 110 2003 1449-1453
174. Fam AG, Siminvitoh KA, Carette S. From L. Neonatal Behcet's syndrome in an infant of a mother with the disease. Am Rheum Dis 1981; 40(5): 509-512.
175. Stark AC, Bhakta B, Chamberlain MA, Dear P, Taylor PV. Life-threatening transient neonatal Behcet's disease. Br J Rheumatol 1997; 36(6): 700-702.